| 000 -LEADER |
|---|
| fixed length control field |
01462nam a22002897a 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20230413113314.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
120912t xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
978924209700 (pbk.) |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
UG |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RA8 T4 W67 no.970 |
| 110 20 - MAIN ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
WHO Expert Committee on Specifications for Pharmaceutical Preparations. |
| 9 (RLIN) |
56330 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
WHO Expert Committee on specifications for pharmaceutical preparations : |
| Remainder of title |
Forty-sixth report. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Geneva, Switzerland : |
| Name of publisher, distributor, etc |
World Health Organisation, |
| Date of publication, distribution, etc |
2012. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xi, 235 p. |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
(WHO technical report series, |
| Volume number/sequential designation |
no:970) |
| 500 ## - GENERAL NOTE |
|---|
| General note |
The WHO Expert Committee met in Geneva from October 10-14, 2011. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references. |
| 541 ## - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Donor |
WHO |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Standards |
| Form subdivision |
Congresses. |
| 9 (RLIN) |
56331 |
|
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Specifications |
| Form subdivision |
Congresses. |
| 9 (RLIN) |
56332 |
|
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Quality control |
| Form subdivision |
Congresses. |
| 9 (RLIN) |
56333 |
|
|---|
| Topical term or geographic name as entry element |
Drug Industry |
| General subdivision |
Standards |
| Form subdivision |
Congresses. |
| 9 (RLIN) |
56334 |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
World Health Organization. |
| 9 (RLIN) |
56335 |
|
|---|
| Corporate name or jurisdiction name as entry element |
WHO Expert Committee on Specifications for Pharmaceutical Preparations 46th : 2011: Geneva Switzerland. |
| 9 (RLIN) |
56336 |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
http://www.who.int/medicines/areas/quality_safety/quality_assurance/expert_committee/TRS-970-pdf1.pdf http://www.who.int/medicines/areas/quality_safety/quality_assurance/expert_committee/TRS-970-pdf1.pdf |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Verified |
TH |
| Entry Department |
TSDC |